Best deals to access real time data! |
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 36.75 ▲ 0.07 (0.19%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.38 | -1.03% | 36.68 | 37.04 | 36.51 | 36.92 | 37.06 | 19:55:24 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 90,339 | 26,309,450 | $ 36.7090 | $ 965.79M | 19.85M | 31.67 - 39.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:38 | formt | 215 | $36.75 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 218.19B | 5.95B | $ 21.31B | 3.57 | 10.20 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.36 | 3.71% | 02/01/2018 | 1.07M | 76.30% |
Pfizer, Inc. News
Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Inva... Business Wire • Mon Apr 23, 2018 8:00 AM (3 days ago)
Pfizer Provides Update on Proposed Trastuzumab Biosimilar Business Wire • Mon Apr 23, 2018 7:45 AM (3 days ago)
MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Co... Business Wire • Mon Apr 23, 2018 7:30 AM (3 days ago)
Pfizer Invites Public to Listen to Webcast of April 26 Annual Meeting of Shareholders Business Wire • Thu Apr 19, 2018 12:38 PM (6 days ago)
Notice of Exempt Solicitation. Definitive Material. (px14a6g) Edgar (US Regulatory) • Wed Apr 18, 2018 6:04 AM (1 week ago)
New York's Commercial-Property Market Storms Back -- WSJ Dow Jones News • Wed Apr 18, 2018 3:02 AM (1 week ago)
A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd. Business Wire • Tue Apr 17, 2018 4:15 PM (1 week ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 36.38 | 37.265 | 36.27 | 36.7412 | 14M | 26M | 18M | 0.3 | 0.82% |
| 1 Month | 35.18 | 37.265 | 34.76 | 36.0026 | 13M | 26M | 17M | 1.5 | 4.26% |
| 3 Months | 37.92 | 37.99 | 33.2 | 35.8009 | 12M | 49M | 21M | -1.24 | -3.27% |
| 6 Months | 36.2 | 39.43 | 33.2 | 36.0887 | 6M | 49M | 18M | 0.48 | 1.33% |
| 1 Year | 33.86 | 39.43 | 31.67 | 34.9217 | 6M | 49M | 18M | 2.82 | 8.33% |
| 3 Years | 34.17 | 39.43 | 28.25 | 33.2980 | 6M | 280M | 23M | 2.51 | 7.35% |
| 5 Years | 28.83 | 39.43 | 27.12 | 31.8959 | 1k | 280M | 26M | 7.85 | 27.23% |
Pfizer, Inc. Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
